# Anti‐Lipogenic Effects of Iridoid‐Rich Lonicera caerulea Berry Extracts in a Cortisol‐Stimulated Adipocyte Model

**Authors:** Liangchuan Guo, Yingjun Cui, Damith Costa, Jinli Qiao, Junwei Huo, H. P. Vasantha Rupasinghe

PMC · DOI: 10.1111/1750-3841.71012 · 2026-03-28

## TL;DR

Haskap berry extracts rich in iridoids reduce fat accumulation and oxidative stress in fat cells, suggesting potential use in functional foods or nutraceuticals.

## Contribution

Demonstrates the anti-lipogenic and antioxidant effects of iridoid-rich haskap berry extracts in a cortisol-stimulated adipocyte model.

## Key findings

- Iridoid-rich extracts significantly reduced cortisol-induced lipid accumulation in 3T3-L1 adipocytes.
- Loganin and loganic acid showed pronounced antioxidant and anti-lipogenic activities.
- Cultivar CBS-5 had the highest total iridoid content, dominated by loganic acid.

## Abstract

Berries of Lonicera caerulea (blue honeysuckle; haskap) have been used since ancient times in traditional medicine in China, Japan, and northern Russia. This study aimed to extract, characterize, and evaluate the biological activity of iridoid‐rich fractions from haskap berries using an in vitro adipocyte model. Liquid chromatography‐mass spectrometry (UPLC–MS) analysis was performed to quantify the major iridoid distribution among ten haskap cultivars. Two iridoid‐enriched extracts were prepared via ultrasonication‐assisted ethanolic extraction followed by C18 solid‐phase fractionation (Extract 1) and subsequent iridoid concentration (Extract 2). Functional evaluation was carried out using a cortisol‐induced 3T3‐L1 adipocyte model. UPLC‐MS revealed pronounced genotypic variation in iridoid profiles among ten cultivars, with CBS‐5 exhibiting the highest total iridoid content (2.42 mg/g dry weight), dominated by loganic acid. UPLC–MS confirmed loganin and loganic acid as the predominant constituents in both extracts. The iridoid‐rich extracts significantly attenuated cortisol‐induced lipid accumulation and intracellular reactive oxygen species generation in 3T3‐L1 adipocytes. Consistently, authentic standards of loganin and loganic acid exhibited pronounced antioxidant and anti‐lipogenic activities. Collectively, these findings indicate that iridoid‐rich extracts from L. caerulea berries may modulate lipid dysregulation and oxidative stress, supporting their potential development as functional food ingredients or nutraceuticals.

Iridoid‐rich haskap berry extracts demonstrate anti‐lipogenic and antioxidant effects in adipocytes, highlighting cultivar selection and extraction strategies for developing functional foods or nutraceutical ingredients targeting stress‐related lipid dysregulation and metabolic health, with potential applications in disease‐prevention formulations and ingredient standardization.

## Linked entities

- **Chemicals:** loganic acid (PubChem CID 89640), loganin (PubChem CID 87691)
- **Species:** Lonicera caerulea (taxon 134520)

## Full-text entities

- **Genes:** Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, Nr1h3 (nuclear receptor subfamily 1, group H, member 3) [NCBI Gene 22259] {aka LXR, RLD1, Unr1}, Slc25a19 (solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19) [NCBI Gene 67283] {aka 2900089E13Rik, DNC, MUP1, TPC}, Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 20787] {aka ADD1, SREBP1, bHLHd1}
- **Diseases:** metabolic disorders (MESH:D008659), cancers (MESH:D009369), lipid (MESH:D011017), neurological disorders (MESH:D009461), inflammation (MESH:D007249), hepatic steatosis (MESH:D005234), hypothalamic-pituitary-adrenal (HPA) axis hyperactivity (MESH:D007029), infections (MESH:D007239), dyslipidemia (MESH:D050171), depression (MESH:D003866), NAFLD (MESH:D065626), obese (MESH:D009765), adipocyte dysfunction (MESH:D006331), disease (MESH:D004194), cytotoxic (MESH:D064420), cardiovascular diseases (MESH:D002318), diabetes mellitus (MESH:D003920)
- **Chemicals:** 2', 7'-Dichlorofluorescin Diacetate (MESH:C029569), ORO (MESH:C011049), ROS (MESH:D017382), ester (MESH:D004952), monoterpenoid (MESH:D039821), acetonitrile (MESH:C032159), PMS (MESH:D008773), Iridoid (MESH:D039823), Iridoid glycosides (MESH:D057889), 3-isobutyl-1-methylxanthine (MESH:D015056), fructose (MESH:D005632), PBS (MESH:D007854), DMSO (MESH:D004121), Loganic acid (MESH:C002947), sweroside (MESH:C049412), CO2 (MESH:D002245), Oleuropein (MESH:C002769), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), polyphenol (MESH:D059808), Flavonoid (MESH:D005419), Trolox (MESH:C010643), oleic acid (MESH:D019301), CE (MESH:D002563), formic acid (MESH:C030544), D-glucose (MESH:D005947), cyclopentane (MESH:D003517), sugars (MESH:D000073893), water (MESH:D014867), isopropanol (MESH:D019840), gallic acid (MESH:D005707), cholesterol (MESH:D002784), DMEM (-), aluminum chloride (MESH:D000077410), Cortisol (MESH:D006854), Gentiopicroside (MESH:C012997), cyanidin-3-O-glucoside (MESH:C462279), Androsin (MESH:C071696), 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MESH:C070380), pyran (MESH:D011714), ethanol (MESH:D000431), anthocyanin (MESH:D000872), carbon (MESH:D002244), catechin (MESH:D002392), Asperuloside (MESH:C077956), paraformaldehyde (MESH:C003043), NaOH (MESH:D012972), 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (MESH:C002502), Lipid (MESH:D008055), fat (MESH:D005223), Loganin (MESH:C059516), triglyceride (MESH:D014280)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Jasminum grandiflorum (species) [taxon 389181], Lonicera caerulea (blue honeysuckle, species) [taxon 134520], Valeriana fauriei (species) [taxon 105907], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** ATCC CL-173 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), AML-12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0140), CL-173 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_3872)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13032163/full.md

---
Source: https://tomesphere.com/paper/PMC13032163